ArticleInternational journal of nanomedicine2021

Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors.

Xin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.